Skip to main content
. 2020 May 27;11:794. doi: 10.3389/fphar.2020.00794

Table 4.

Final model parameter estimates of the original population pharmacokinetic (POPPK) model developed by Svensson et al. (2018a) compared to final parameter estimates of the re-estimated POPPK model without inter-occasion variability (IOV).

Parameter Description Estimates original model Estimates model without IOV (RSE [%])
Vmax (mg/h/70 kg) Maximal elimination rate 525 309.8 (19.9%)
km (mg/L) Concentration at which half of the elimination is reached 35.3 15.8 (19.5%)
V (L/70 kg) Volume of distribution 87.2 93.6 (8.0%)
ka (h−1) Absorption rate constant 1.77 2.4 (43.2%)
MTT (h) Mean transit time 0.51 0.81 (16.0%)
NN Number of transit compartments 23.8 7.6 (25.7%)
Emax Maximal increase in enzyme production rate 1.16 1.2 (11.6%)
EC50 (mg/L) Concentration at which half Emax is reached 0.0699 0.053 (125.6%)
kENZ (h−1) First-order rate constant for enzyme degradation and formation 0.00603 0.0053 (25.0%)
Fmax Maximal increase in bioavailability with doses above 450 mg 0.504 0.40 (33.9%)
ED50 (mg) The dose at which half Fmax is reached 67.0 17.4 (374.4%)
IIV Vmax (%) Inter-individual variability in Vmax 30.0 55.2 (17.7%)
IIV km (%) Inter-individual variability in km 35.8 80.6 (13.8%)
IIV V (%) Inter-individual variability in V 7.86 8.6 (64.4%)
IIV ka (%) Inter-individual variability in ka 33.8 28.7 (174.8%)
IIV MTT (%) Inter-individual variability in MTT 38.2 58.8 (18.8%)
IIV NN (%) Inter-individual variability in NN 77.9 90.5 (18.3%)
IOV km (%) Inter-occasion variability in km 18.9 0 FIX
IOV ka (%) Inter-occasion variability in ka 31.4 0 FIX
IOV MTT (%) Inter-occasion variability in MTT 56.4 0 FIX
IOV F (%) Inter-occasion variability in F 15.7 0 FIX
Correlation Vmax-Km (%) 38.9 59.6 (15.9%)
(%) Additive error on log scale 23.6 56.9 (0.9%)

IOV, inter-occasion variability; RSE, relative standard error reported on the approximate standard deviation scale.